Adverse effects of antiepileptics

Area of Science:

• Pharmacology
• Clinical Pharmacy
• Neurology

Background:

• Anticonvulsant medications are essential for managing epilepsy and other seizure disorders.
• Patient selection for anticonvulsant therapy involves a multifactorial approach.
• Adverse effects are a significant concern in anticonvulsant treatment, impacting up to one-third of patients.

Purpose of the Study:

• To provide a comprehensive overview of factors influencing anticonvulsant drug selection.
• To categorize and discuss the adverse effects associated with anticonvulsant therapy.
• To emphasize the importance of postmarketing surveillance for newer anticonvulsants.

Main Methods:

• Review of existing literature on anticonvulsant drug selection criteria.
• Categorization of anticonvulsant adverse effects into dose-related and idiosyncratic toxicity.
• Discussion of adverse events based on the organ system affected.

Main Results:

• Key considerations for anticonvulsant selection include efficacy, pharmacokinetics, cost, teratogenicity, and patient-specific factors (age, sex).
• Adverse effects are broadly classified into common dose-related toxicity and less predictable idiosyncratic toxicity.
• Both common and idiosyncratic adverse events manifest across various organ systems.

Conclusions:

• Informed anticonvulsant drug selection necessitates balancing therapeutic benefits with potential risks.
• Understanding the spectrum of adverse effects, from common to rare, is vital for effective patient management.
• Ongoing postmarketing surveillance is critical for identifying and mitigating rare or chronic toxicities associated with newer anticonvulsants.